Anusha K H, Thyagaraju Chitra, Nandeesha H
Department of Obstetrics and Gynaecology, JIPMER, Puducherry, India.
J Hum Reprod Sci. 2024 Oct-Dec;17(4):269-274. doi: 10.4103/jhrs.jhrs_155_24. Epub 2024 Dec 23.
Thyroid auto-antibodies could be one of the many causes of infertility in women, especially with polycystic ovarian syndrome (PCOS) with a prevalence of 5%-15%. Patients with anti-thyroid antibodies have shown significantly lower fertilisation rates, implantation rates, lower pregnancy rates and increased risk of first-trimester abortions when compared with those without anti-thyroid antibodies.
The aim of the study was to assess the prevalence of thyroid auto-antibodies in euthyroid infertile women with PCOS and to compare the prevalence of thyroid autoantibodies in euthyroid infertile women with PCOS and without PCOS.
This is a cross sectional analytical study involving 132 Infertile women with and without PCOS visiting the department of OBG in a tertiary care center. The study was conducted for period of 2 years.
A total of one hundred two women were enrolled in to the study. Sixty six women (66) had features of PCOS based on Rotterdam's criteria and 66 women were controls without PCOS features. Detailed history and examination were done for all women after taking informed and written consent. Previous hospital records were collected along with all biochemical investigations. The blood sample was collected for hormonal levels and thyroid auto-antibodies (anti-thyroid peroxidase [TPO] and anti-thyroglobulin [TG]) were assessed by enzyme-linked immunosorbent assay. The antibody levels were compared between the two groups along with the other parameters.
Statistical tests were done using SPSS version 26. The Chi-square test or Fisher's exact test would be used to study the association of categorical data like the presence of hirsutism, acne, etc. The association of independent variables with outcome variables was assessed using Chi-square. The P < 0.05 was considered significant with a confidence interval of 95%.
Anti-TPO antibody levels were found to be elevated in 25.4% of the PCOS group in comparison to only 3% of the non-PCOS group. Anti-TG antibodies of >100 U/mL were seen in 23 patients (34.3%) in PCOS group in comparison to two patients (3%) in non-PCOS group (P = 0.001). Both the antibodies (anti-TPO and anti-TG) were present in 21.2% of the PCOS group and 1.5% of the non-PCOS group.
Women with PCOS were found to be 11 times more likely to have anti-TPO antibodies and 20 times more likely to have anti-TG antibodies compared to non-PCOS women. This heightened prevalence of anti-thyroid antibodies suggests that testing for these antibodies may be warranted in women with PCOS, even if they have normal thyroid function. However, further studies with larger sample sizes are needed to validate these findings.
甲状腺自身抗体可能是女性不孕的众多原因之一,尤其是在多囊卵巢综合征(PCOS)患者中,其患病率为5%-15%。与没有抗甲状腺抗体的患者相比,有抗甲状腺抗体的患者受精率、着床率显著降低,妊娠率降低,且孕早期流产风险增加。
本研究旨在评估甲状腺功能正常的PCOS不孕女性中甲状腺自身抗体的患病率,并比较甲状腺功能正常的PCOS不孕女性与非PCOS不孕女性中甲状腺自身抗体的患病率。
这是一项横断面分析研究,涉及132名到三级医疗中心妇产科就诊的有无PCOS的不孕女性。该研究持续了2年。
共有102名女性纳入研究。66名女性(66)根据鹿特丹标准具有PCOS特征,66名女性为无PCOS特征的对照组。在获得知情书面同意后,对所有女性进行了详细的病史询问和检查。收集了既往医院记录以及所有生化检查结果。采集血样检测激素水平,并通过酶联免疫吸附测定法评估甲状腺自身抗体(抗甲状腺过氧化物酶[TPO]和抗甲状腺球蛋白[TG])。比较两组之间的抗体水平以及其他参数。
使用SPSS 26版进行统计检验。卡方检验或Fisher精确检验用于研究多毛症、痤疮等分类数据的相关性。使用卡方检验评估自变量与结果变量之间的相关性。P<0.05被认为具有统计学意义,置信区间为95%。
PCOS组中25.4%的患者抗TPO抗体水平升高,而非PCOS组仅为3%。PCOS组23例患者(34.3%)抗TG抗体>100 U/mL,非PCOS组2例患者(3%)(P=0.001)。PCOS组21.2%的患者同时存在两种抗体(抗TPO和抗TG),非PCOS组为1.5%。
与非PCOS女性相比,PCOS女性出现抗TPO抗体的可能性高11倍,出现抗TG抗体的可能性高20倍。抗甲状腺抗体的这种较高患病率表明,即使甲状腺功能正常,PCOS女性也可能需要检测这些抗体。然而,需要进一步进行更大样本量的研究来验证这些发现。